| Combination of | |
|---|---|
| Dexamethasone | Corticosteroid |
| Levofloxacin | Anti-infective |
| Clinical data | |
| Trade names | Levodexa |
| Routes of administration | Eye drops |
| ATC code | |
| Legal status | |
| Legal status | |
Dexamethasone/levofloxacin, sold under the brand nameLevodexa, is afixed-dose combination medication used for the prevention and treatment of inflammation, and the prevention of infection, associated withcataract surgery.[1][3] It containsdexamethasone, acorticosteroid; andlevofloxacin, ananti-infective.[1]
It was approved for medical use in Canada in December 2023.[1]
Dexamethasone/levofloxacin isindicated for the prevention and treatment of inflammation, and the prevention of infection, associated with cataract surgery in adults.[1]
 | Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |
